Mark Naples Selected Research

Mark Naples Research Topics

Disease

14	Insulin Resistance 12/2014 - 06/2004
10	Dyslipidemias (Dyslipidemia) 05/2015 - 11/2004
5	Type 2 Diabetes Mellitus (MODY) 05/2015 - 11/2004
4	Hypertriglyceridemia 12/2014 - 06/2004
3	Inflammation (Inflammations) 12/2014 - 06/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2013 - 01/2011
3	Obesity 01/2013 - 05/2012
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 11/2004
2	Body Weight (Weight, Body) 12/2014 - 01/2013
2	Hyperlipidemias (Hyperlipidemia) 01/2013 - 06/2004
2	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 06/2012 - 08/2007
2	Fatty Liver 03/2012 - 12/2008
2	Glucose Intolerance 03/2012 - 08/2009
1	Alcoholic Fatty Liver 07/2016
1	Pain (Aches) 01/2016
1	Osteoarthritis 01/2016
1	Hyperinsulinism (Hyperinsulinemia) 12/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2014
1	Hypercholesterolemia 05/2012
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 05/2012
1	Neoplasms (Cancer) 12/2008
1	Hepatocellular Carcinoma (Hepatoma) 12/2004
1	Weight Gain 12/2004

Drug/Important Bio-Agent (IBA)

14	Insulin (Novolin)FDA Link 05/2015 - 06/2004
9	FructoseIBA 12/2014 - 06/2004
8	Lipoproteins (Lipoprotein)IBA 01/2013 - 06/2004
6	LipidsIBA 12/2014 - 11/2004
4	CholesterolIBA 07/2016 - 08/2009
3	Messenger RNA (mRNA)IBA 12/2014 - 08/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 01/2011
3	Tyrosine (L-Tyrosine)FDA Link 08/2009 - 12/2004
3	Proteins (Proteins, Gene)FDA Link 08/2009 - 12/2004
3	ApolipoproteinsIBA 06/2009 - 03/2006
2	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2015 - 12/2014
2	ChylomicronsIBA 05/2015 - 05/2012
2	VLDL LipoproteinsIBA 12/2014 - 05/2012
2	SterolsIBA 01/2013 - 05/2006
2	Triglycerides (Triacylglycerol)IBA 05/2012 - 08/2007
2	Rosuvastatin Calcium (Crestor)FDA Link 05/2008 - 03/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2008 - 03/2006
2	Rosiglitazone (Avandia)FDA Link 01/2005 - 06/2004
1	Sucrose (Saccharose)IBA 07/2016
1	InflammasomesIBA 07/2016
1	Exenatide (Byetta)FDA Link 12/2014
1	Glucagon-Like Peptide-1 ReceptorIBA 12/2014
1	IncretinsIBA 12/2014
1	Hormones (Hormone)IBA 12/2014
1	CarbohydratesIBA 12/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2014
1	CeramidesIBA 05/2013
1	Sterol Regulatory Element Binding Protein 1IBA 05/2013
1	thermozymocidin (myriocin)IBA 05/2013
1	safingol (sphinganine)IBA 05/2013
1	SphingolipidsIBA 05/2013
1	SphingosineIBA 05/2013
1	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 01/2013
1	Investigational DrugsIBA 01/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2013
1	LDL Receptors (LDL Receptor)IBA 06/2012
1	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 06/2012
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 05/2012
1	Ezetimibe (Zetia)FDA Link 05/2012
1	Janus Kinase 2IBA 03/2012
1	C-Reactive ProteinIBA 01/2011
1	Mitogen-Activated Protein KinasesIBA 01/2011
1	Liver X ReceptorsIBA 08/2009
1	Dietary Fats (Dietary Fat)IBA 08/2009
1	Blood Glucose (Blood Sugar)IBA 08/2009
1	Dietary CholesterolIBA 08/2009
1	Insulin ReceptorIBA 08/2009
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 08/2009
1	NF-kappa B (NF-kB)IBA 06/2009
1	TensinsIBA 12/2008
1	Apolipoproteins B (ApoB)IBA 12/2008
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2008
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2008
1	HDL CholesterolIBA 08/2007
1	CytokinesIBA 08/2007
1	Transcription Factors (Transcription Factor)IBA 08/2007
1	Phosphotransferases (Kinase)IBA 05/2006
1	ElementsIBA 05/2006
1	Apolipoprotein B-48IBA 05/2006
1	Nonesterified Fatty Acids (NEFA)IBA 03/2005
1	Oleic Acid (Oleate)IBA 03/2005
1	microsomal triglyceride transfer proteinIBA 03/2005
1	Small Interfering RNA (siRNA)IBA 12/2004
1	Lipase (Acid Lipase)FDA Link 11/2004

Therapy/Procedure

2	Therapeutics 01/2016 - 05/2015
1	Glycemic Control 01/2013
1	Intravenous Administration 01/2011